Key Metrics
CiteScore 

3.6
H-Index 

97
Impact Factor 

< 5
SJR 

Q3Genetics

SNIP 

0.64
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmacogenomics
Pharmacogenomics Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacogenomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
Long non-coding RNAs and survival outcomes in chronic lymphocytic leukemia.
- 15 May 2026
- Pharmacogenomics
Pharmacogenomics of current antiretroviral drugs.
- 12 May 2026
- Pharmacogenomics
Prioritizing drugs for future clinical pharmacogenomics studies in Saudi Arabia: a generalizable multi-criteria framework.
- 10 May 2026
- Pharmacogenomics
Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain.
- 8 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics
Genetics of tardive dyskinesia: a review of progress over the past decade.
- 18 May 2026
- Pharmacogenomics
Long non-coding RNAs and survival outcomes in chronic lymphocytic leukemia.
- 15 May 2026
- Pharmacogenomics
Pharmacogenomics of current antiretroviral drugs.
- 12 May 2026
- Pharmacogenomics
Prioritizing drugs for future clinical pharmacogenomics studies in Saudi Arabia: a generalizable multi-criteria framework.
- 10 May 2026
- Pharmacogenomics
Pharmacogenetics of venlafaxine response in older adults with depression and chronic lower back pain.
- 8 May 2026
- Pharmacogenomics
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer.
- 19 Apr 2026
- Pharmacogenomics